Irbesartan And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 62332-053

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Irbesartan And Hydrochlorothiazide (NDC 62332-053). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Irbesartanhctz Figure 12

Four charts showing probabilities of achieving systolic blood pressure (SBP) and diastolic blood pressure (DBP) targets in patients from Initial Therapy Studies V and VI at Weeks 7 and 8. The graphs depict baseline SBP/DBP on the x-axes and the percentage of patients achieving SBP <140 and <130 mmHg, and DBP <90 and <80 mmHg on the y-axes, with data series differentiated by study and treatment groups.*

FDA Label Image

Irbesartanhctz Figure 34

Two integrated analysis plots show placebo-subtracted reduction in trough systolic blood pressure (SeSBP) and diastolic blood pressure (SeDBP) versus irbesartan dose in mg/day. The left graph depicts reduction in systolic BP with doses ranging up to 900 mg/day, while the right graph shows similar reduction in diastolic BP over the same dose range.*

FDA Label Image

Structure (Irbesartanhctz Hctz)

Chemical structure of Irbesartan and Hydrochlorothiazide, showing the molecular arrangement of atoms and bonds typical to this active ingredient combination in tablet form.*

FDA Label Image

Structure (Irbesartanhctz Irbe)

Chemical structure diagram of Irbesartan, the active ingredient in Irbesartan and Hydrochlorothiazide tablets. The diagram shows the molecular configuration using common chemical bond notation.*

FDA Label Image

Irbesartanhctz mg150125

Label for Irbesartan and Hydrochlorothiazide Tablets, USP, strength 150 mg/12.5 mg. The oral tablet packaging label includes dosage information, storage instructions, manufacturer details (Alembic Pharmaceuticals Limited, India, and Alembic Pharmaceuticals, Inc., USA), NDC number 62332-051-30, and a quantity of 30 tablets. The label is marked Rx only and features the Alembic logo.*

FDA Label Image

Irbesartanhctz mg300125

Packaging label for Irbesartan and Hydrochlorothiazide Tablets, USP with strength 300 mg/12.5 mg. The label shows a package size of 30 tablets and indicates prescription use only (Rx only). It includes manufacturer information for Alembic Pharmaceuticals Limited in India and Alembic Pharmaceuticals, Inc. in the USA. A barcode, NDC 62332-052-30, and storage instructions are also visible.*

FDA Label Image

Irbesartanhctz mg30025

Packaging label for Irbesartan and Hydrochlorothiazide Tablets, USP, strength 300 mg/25 mg. The label indicates 30 tablets in the package, prescription only, manufactured by Alembic Pharmaceuticals Limited, Gujarat, India, and for Alembic Pharmaceuticals, Inc., Bedminster, NJ. It includes storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.